chlorambucil

Poland

Drugs containing this active substance

  • LEUKERAN

    The medicine is intended for the treatment of certain types of blood and lymphatic cancers, such as Hodgkin's disease, non-Hodgkin's lymphomas, chronic lymphocytic leukemia, and Waldenström's macroglobulinemia.

    Form: tablets, film-coated

    Active substance Dosage
    chlorambucil 2 mg

    ATC: L01AA02

    Manufacturer: Excella GmbH & Co. KG GlaxoSmithKline Pharmaceuticals S.A.